Frequently Asked Questions
The market is segmented based on , By Test Type (Cholesterol Tests, Diabetes Test, Cancer Screening, General Check Up Test, STDs, Blood Pressure Test, Others), Package Type (Basic Health Screening, Senior Citizen Profile, Women Health Check, Men Health Check, Heart Check, Diabetes Check, Others), Panel Type (Multi-Test Panels, Single-Test Panels), Sample Type (Blood, Urine, Serum, Saliva, Others), Technology (Immunoassays, Medical Imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in Situ Hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis), Others), Condition (Cardiovascular Disease, Metabolic Disorders, Cancer, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions, Others), Sample Collection Sites (Hospital, Homes, Diagnostic Laboratories, Offices, Others), Distribution Channel (Direct Tenders, Retail Sales, Others) - Industry Trends and Forecast to 2031.
.
The Global Health Screening Market size was valued at USD 291272.40 USD Million in 2023.
The Global Health Screening Market is projected to grow at a CAGR of 12.5% during the forecast period of 2024 to 2031.
The major players operating in the market include Quest Diagnostics orporated, GRAIL, Eurofins Scientific, Exact Sciences Corporation, SYNLAB International GmbH, UNILABS, LabPLUS, BioReference Laboratories, Sonic Healthcare Limited, ACM Global Laboratories, Cerba Healthcare, Quidel Corporation, Innova Medical Group, Amedes Holding GmbH, RadNet , Natera , Trinity Biotech, Nuffield Health, RepeatDx, NeoGenomics Laboratories, H.U Group Holdings , ARUP Laboratories, Q2 Solutions, Genova Diagnostics.
The market report covers data from the U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E., Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa.
